Enwei Pharmaceutical Co., Ltd. (SZSE: 301331)
Health Care · Pharmaceuticals · CN
CN¥22.29
+4.70% today · -36.7% 1Y
Enwei Pharmaceutical Co., Ltd. (SZSE: 301331) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $336.69M.
Over the last twelve months the share price has lost 36.7%, trading between 18.87 and 39.66.
Tweenvest scores Enwei Pharmaceutical Co., Ltd. across four factors: quality 67/100, value 50/100, growth 65/100, dividend 50/100. Its strongest factor is quality.
301331 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $336.69M
- Revenue (TTM)
- $127.53M
- P/E
- 48.08
- EPS
- 0.46
- Dividend yield
- 2.96%
- Beta (5Y)
- 0.57
- 52-week high
- CN¥39.66
- 52-week low
- CN¥18.87
- Avg volume (3M)
- —
- Shares outstanding
- 101.88M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.